Filed: Jun. 12, 2017
Latest Update: Jun. 12, 2017
Summary: ORDER GRANTING CONSENT MOTION TO STAY DISCOVERY G.R. SMITH , Magistrate Judge . Defendants Bristol-Myers Squibb Company ("BMS"), Otsuka America Pharmaceutical, Inc. ("OAPI"), Claxton-Graves, Inc. ("Claxton-Graves), and John Doe 3 (collectively, "Defendants"), having moved that the Court stay discovery pending the Court's ruling on Defendants' Motions to Dismiss filed on May 24, 2017, and good cause having been shown for the grant of same, the Motion to Stay is hereby GRANTED. Discovery an
Summary: ORDER GRANTING CONSENT MOTION TO STAY DISCOVERY G.R. SMITH , Magistrate Judge . Defendants Bristol-Myers Squibb Company ("BMS"), Otsuka America Pharmaceutical, Inc. ("OAPI"), Claxton-Graves, Inc. ("Claxton-Graves), and John Doe 3 (collectively, "Defendants"), having moved that the Court stay discovery pending the Court's ruling on Defendants' Motions to Dismiss filed on May 24, 2017, and good cause having been shown for the grant of same, the Motion to Stay is hereby GRANTED. Discovery and..
More
ORDER GRANTING CONSENT MOTION TO STAY DISCOVERY
G.R. SMITH, Magistrate Judge.
Defendants Bristol-Myers Squibb Company ("BMS"), Otsuka America Pharmaceutical, Inc. ("OAPI"), Claxton-Graves, Inc. ("Claxton-Graves), and John Doe 3 (collectively, "Defendants"), having moved that the Court stay discovery pending the Court's ruling on Defendants' Motions to Dismiss filed on May 24, 2017, and good cause having been shown for the grant of same, the Motion to Stay is hereby GRANTED.
Discovery and all other deadlines are stayed pending the disposition of the Motions to Dismiss and further Order of this Court.
SO ORDERED.
